Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA saysOzempic and Wegovy shortages are resolved, but distribution issues may persist as supply improves.
Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA saysOzempic and Wegovy supply shortages have been resolved, allowing for improved access to diabetes and obesity treatments.
FDA declares end to Wegovy and Ozempic shortageThe FDA declared an end to the national shortage of Ozempic and Wegovy medications.Novo Nordisk met and exceeded the U.S. demand for semaglutide products.
Breakthrough Prizes Awarded to Obesity-Drug Pioneers and Large Hadron Collider PhysicistsThe development of Ozempic and Wegovy has significantly impacted weight loss and diabetes treatment, earning the scientists involved a prestigious award.
HIMS is Out. Is Novo Nordisk or Eli Lilly the Better GLP-1 Buy?Novo Nordisk's Ozempic and Wegovy shortage is resolved, enhancing its market position and pricing power.
The Ozempic Shortage Is OverThe FDA has declared semaglutide no longer in shortage, affecting cheaper compounded versions and signaling significant market changes.
Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA saysOzempic and Wegovy shortages are resolved, but distribution issues may persist as supply improves.
Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA saysOzempic and Wegovy supply shortages have been resolved, allowing for improved access to diabetes and obesity treatments.
FDA declares end to Wegovy and Ozempic shortageThe FDA declared an end to the national shortage of Ozempic and Wegovy medications.Novo Nordisk met and exceeded the U.S. demand for semaglutide products.
Breakthrough Prizes Awarded to Obesity-Drug Pioneers and Large Hadron Collider PhysicistsThe development of Ozempic and Wegovy has significantly impacted weight loss and diabetes treatment, earning the scientists involved a prestigious award.
HIMS is Out. Is Novo Nordisk or Eli Lilly the Better GLP-1 Buy?Novo Nordisk's Ozempic and Wegovy shortage is resolved, enhancing its market position and pricing power.
The Ozempic Shortage Is OverThe FDA has declared semaglutide no longer in shortage, affecting cheaper compounded versions and signaling significant market changes.
How Much Should Weight Loss Drugs Like Wegovy and Zepbound Cost?The cost of weight loss drugs Wegovy and Zepbound outweighs their health benefits, as per a study from the University of Chicago.
Decades-old law limits access to Wegovy for Medicaid beneficiariesMedicaid plans not required to cover Wegovy for weight loss/obesity, despite effectiveness, due to old law.
Which Weight-Loss Drug Is Better: Wegovy or Zepbound?Zepbound leads to more weight loss than Wegovy in clinical trials.
How Much Should Weight Loss Drugs Like Wegovy and Zepbound Cost?The cost of weight loss drugs Wegovy and Zepbound outweighs their health benefits, as per a study from the University of Chicago.
Decades-old law limits access to Wegovy for Medicaid beneficiariesMedicaid plans not required to cover Wegovy for weight loss/obesity, despite effectiveness, due to old law.
Which Weight-Loss Drug Is Better: Wegovy or Zepbound?Zepbound leads to more weight loss than Wegovy in clinical trials.
Weight Loss Drug Will Be Offered for $499 a Month for Some PatientsNovo Nordisk reduces Wegovy's price to $499 for cash-paying patients, but government-insured patients still face high costs.
New Study Finds Wegovy Reduces COVID Death Risk By 33 PercentNovo Nordisk's Wegovy reduces COVID-19 mortality risk by one-third in obese patients, indicating potential health benefits beyond obesity treatment.
The Wegovy shortage is causing thousands to turn to copies. What will the FDA do about it?The FDA is considering removing Wegovy from its shortage list, which impacts compounded versions being provided to patients.Compounded drugs are filling the gap for many patients who can't afford or find Wegovy, highlighting their role in treatment options.
Novo Nordisk confident despite Trump tariff risk as sales of weight-loss jab soarNovo Nordisk remains confident in its business despite potential US tariff threats, reporting strong revenue growth fueled by its weight-loss drugs.
Novo Nordisk's Wegovy sales jump on international rolloutsWegovy's sales surged 79%, exceeding expectations, offering reassurance to investors amid growing competition in the obesity drug market.
Wegovy reduced COVID deaths in obese patients, study showsWegovy significantly reduced deaths and illness from COVID-19 during a large study, showcasing its benefits beyond weight loss.
Weight Loss Drug Will Be Offered for $499 a Month for Some PatientsNovo Nordisk reduces Wegovy's price to $499 for cash-paying patients, but government-insured patients still face high costs.
New Study Finds Wegovy Reduces COVID Death Risk By 33 PercentNovo Nordisk's Wegovy reduces COVID-19 mortality risk by one-third in obese patients, indicating potential health benefits beyond obesity treatment.
The Wegovy shortage is causing thousands to turn to copies. What will the FDA do about it?The FDA is considering removing Wegovy from its shortage list, which impacts compounded versions being provided to patients.Compounded drugs are filling the gap for many patients who can't afford or find Wegovy, highlighting their role in treatment options.
Novo Nordisk confident despite Trump tariff risk as sales of weight-loss jab soarNovo Nordisk remains confident in its business despite potential US tariff threats, reporting strong revenue growth fueled by its weight-loss drugs.
Novo Nordisk's Wegovy sales jump on international rolloutsWegovy's sales surged 79%, exceeding expectations, offering reassurance to investors amid growing competition in the obesity drug market.
Wegovy reduced COVID deaths in obese patients, study showsWegovy significantly reduced deaths and illness from COVID-19 during a large study, showcasing its benefits beyond weight loss.
How to trick the body's metabolismNew research suggests a way to maintain calorie burning during weight loss despite reduced calorie intake.
Weight-loss drug linked to fewer COVID deaths - Harvard GazetteWegovy significantly reduces the risk of death from cardiovascular disease and COVID-19-related complications in overweight individuals.
WeightWatchers stock price skyrockets on news that it will offer a compounded GLP-1 weight-loss drug like WegovyWeightWatchers introduces compounded Wegovy to tackle weight-loss industry challenges and capitalize on medication shortages.
'I feel blessed to get weight-loss jab' - but can the NHS afford it for all?Wegovy shows promise for aiding weight loss, but limited access raises concerns about the NHS's financial sustainability amid rising obesity rates.
The Longest Clinical Trial Yet Of Blockbuster Weight Loss Drug Wegovy Reveals Significant Side EffectsGLP-1 agonists like Wegovy show significant weight loss and may have long-lasting effects, but concerns exist regarding side effects.
Long-term Wegovy study finds weight loss plateaus a little after a yearWeight loss on Wegovy plateaus after 65 weeks but is maintained over 4 years with a significant difference from the placebo group.
How to trick the body's metabolismNew research suggests a way to maintain calorie burning during weight loss despite reduced calorie intake.
Weight-loss drug linked to fewer COVID deaths - Harvard GazetteWegovy significantly reduces the risk of death from cardiovascular disease and COVID-19-related complications in overweight individuals.
WeightWatchers stock price skyrockets on news that it will offer a compounded GLP-1 weight-loss drug like WegovyWeightWatchers introduces compounded Wegovy to tackle weight-loss industry challenges and capitalize on medication shortages.
'I feel blessed to get weight-loss jab' - but can the NHS afford it for all?Wegovy shows promise for aiding weight loss, but limited access raises concerns about the NHS's financial sustainability amid rising obesity rates.
The Longest Clinical Trial Yet Of Blockbuster Weight Loss Drug Wegovy Reveals Significant Side EffectsGLP-1 agonists like Wegovy show significant weight loss and may have long-lasting effects, but concerns exist regarding side effects.
Long-term Wegovy study finds weight loss plateaus a little after a yearWeight loss on Wegovy plateaus after 65 weeks but is maintained over 4 years with a significant difference from the placebo group.
Consultations for obesity drug prescriptions are way up over 2023, survey findsThe demand for consultations about obesity drugs is surging, particularly influenced by social factors and public figures.
Novo Nordisk sells hit weight-loss drug in China-at fraction of US priceWegovy's price in China is substantially lower than in the US, highlighting global disparities in drug pricing.
Novo Nordisk launches Wegovy in China with prices well below U.S.Wegovy launches in China at lower prices than the US, but patients must bear costs individually.
Novo Nordisk sells hit weight-loss drug in China-at fraction of US priceWegovy's price in China is substantially lower than in the US, highlighting global disparities in drug pricing.
Novo Nordisk launches Wegovy in China with prices well below U.S.Wegovy launches in China at lower prices than the US, but patients must bear costs individually.
Wegovy reduced Covid deaths in obese patients, study findsWegovy showed benefits beyond weight loss, reducing Covid-related deaths and illnesses in a large clinical trial among people with obesity.
An Obesity Drug Prevents Covid Deaths, Study SuggestsWegovy significantly reduces the risk of death from Covid-19 among users, highlighting its potential additional benefits beyond weight loss.
Wegovy reduced Covid deaths in obese patients, study findsWegovy showed benefits beyond weight loss, reducing Covid-related deaths and illnesses in a large clinical trial among people with obesity.
An Obesity Drug Prevents Covid Deaths, Study SuggestsWegovy significantly reduces the risk of death from Covid-19 among users, highlighting its potential additional benefits beyond weight loss.
How People Are Overdosing on Semaglutide Drugs like Ozempic and WegovyBe cautious of semaglutide overdoses; they can lead to serious health complications and hospitalization.